Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Long-Term Treatment With Rhinocort Aqua (Budesonide) Nasal Spray in Children With Perennial Allergic Rhinitis.

NCT00641212 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00641212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00641212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Long-Term Treatment With Rhinocort Aqua (Budesonide) Nasal Spray in Children With Perennial Allergic Rhinitis.
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2000
Completion date
April 30, 2003
Enrollment
209 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

perennial allergic rhinitis